NMNH
NMNH Powder | Reduced Nicotinamide Mononucleotide Headline: Next-Gen NAD+ Booster: NMNH Powder Manufacturer | Reduced Form (CAS: 108347-85-9) Sub-info: Assay: ≥98% (HPLC) | Form: Amorphous Yellow Powder | Super-Potent NMN Alternative USP: 5x More Potent Than NMN • Faster NAD+ Elevation • Oxygen-Free Packaging
Introduction
NMNH (Reduced Nicotinamide Mononucleotide) is the cutting-edge, decreased shape of NMN. Whereas NMN has overwhelmed the life span advertise, later breakthrough investigate (2021) uncovers that NMNH is a distant predominant NAD+ enhancer.
It acts as a strong forerunner to NAD+, competent of expanding cellular NAD+ levels quicker, higher, and for longer lengths than standard NMN or NR. Our NMNH is synthesized beneath strict anaerobic conditions to guarantee greatest soundness and bioactivity for premium anti-aging formulations.
Category：
Keywords：
natural
rosmarinic
preservative
Functions
1. Unrivaled NAD+ Rebuilding
NMNH is metabolized in an unexpected way than NMN. Thinks about appear it can increment NAD+ levels in the liver and kidney by up to 2-fold higher than the same measurement of NMN, making it the most proficient NAD+ booster found to date.
2. Supported Bioactivity
Not at all like NMN, which is quickly metabolized, NMNH illustrates a maintained impact on NAD+ rise in tissues, keeping up tall levels for expanded periods. This proposes a possibly lower day by day dose necessity for consumers.
3. Hypoxia Security & Cell Repair
By drastically boosting mitochondrial work, NMNH upgrades cell survival beneath hypoxic (moo oxygen) conditions and advances the repair of renal tubular epithelial cells.
Applications
Next-Gen Life span Supplements:
• High-End Capsules: For premium brands looking to offer a product superior to generic NMN.
• Synergistic Blends: Often combined with Resveratrol or PQQ for mitochondrial health.
Pharmaceutical Research:
• Investigated for its potential in treating acute kidney injury (AKI) and metabolic disorders.
Functional Formulations:
• Due to its reducing nature, it requires specialized oil-suspension or nitrogen-flushed packaging technologies.
Flow Chart
Precursor Preparation → Catalytic Hydrogenation (Reduction Process) → Anaerobic Filtration → Purification (Chromatography) → Concentration (Low Temp) → Lyophilization (Freeze Drying) → Nitrogen-Protected Milling → Vacuum Sealing
Note: The entire production line is oxygen-free to prevent oxidation of NMNH back into NMN.
Quality Standard of Lactoferrin
| Item | Specification | Result |
| Appearance | Yellow to bright yellow powder | Conforms |
| Assay (HPLC) | ≥ 98.0% | 98.5% |
| NMN Content | ≤ 1.0% (Oxidation by-product) | 0.4% |
| Water Content | ≤ 2.0% | 1.1% |
| pH (1% Solution) | 6.0 – 8.0 | 7.2 |
| Heavy Metals | ≤ 10 ppm | < 5 ppm |
| Arsenic (As) | ≤ 1.0 ppm | < 0.1 ppm |
| Total Plate Count | ≤ 1,000 cfu/g | < 100 cfu/g |
| Solubility | Soluble in water | Conforms |
Method of Analysis of Lactoferrin
We use HPLC-UV or LC-MS (Liquid Chromatography-Mass Spectrometry).
• Critical Distinction: Standard HPLC can sometimes confuse NMN and NMNH. Our validated method separates the two peaks clearly, ensuring you are buying the active Reduced form (NMNH), not just oxidized NMN.
Reference Chromatogram of Lactoferrin Reference Substance
(Imagine a chromatogram with distinct retention times) The reduced NMNH peak appears at a specific retention time distinct from the NMN impurity peak. The spectrum confirms the molecular mass corresponding to C11H17N2O8P (Reduced form).
Stability and Safety
Stability Studies
• Storage: Must be stored at -20°C (Freezer) for long-term storage.
• Shipping: Shipped with ice packs and vacuum-sealed double aluminum bags.
• Stability Data: At -20°C, purity remains >98% for 24 months. At room temperature (25°C), it slowly oxidizes to NMN over weeks if exposed to air.
• Formulation Advice: We recommend encapsulation in Nitrogen-purged capsules or softgels to protect the ingredient.
Safety & Handling (MSDS Summary)
• Classification: Novel food ingredient / R&D Chemical.
• Handling: Handle in a glove box or low-oxygen environment if possible. Do not leave open to air.
• Safety: Preliminary studies in mice show no toxicity at effective doses.
Customer Comments
CEO, Innovative Biotech Startup (USA)
2026.02.11
★★★★★
Lab Director, European Research Institute
2026.02.11
★★★★★
Our Certificates
CERTIFICATE
CERTIFICATE
FDA
ISO
HALAL
HACCP
Our Clients
Exhibitions
• SupplySide West (Las Vegas)
• Vitafoods Europe (Geneva)
• BioJapan (Yokohama)
Vitafoods Europe (Geneva)
CPhI Worldwide
In-Cosmetics Global
FIC 2022
CPHI & PMEC 2024
CPHI & PMEC China Shanghai
CPHI & PMEC China 2025
SupplySide West (Las Vegas)
CAC Shanghai
SupplySide West (Las Vegas)
CPHI 2025
CPHI 2024
CPHI 2023
CAC 24th
FIC 2023
FIC Shanghai
FIC2024
CPHI Korea
SupplySideWEST Las Vegas
SupplySideWEST 2023
Vitafoods Europe Switzerland
Wagri Guangzhou
FAQ
What is the main difference between NMN and NMNH?
NMNH is the "Reduced" form of NMN. Chemically, it carries two extra hydrogen atoms. Biologically, this makes it much more potent. Research suggests NMNH increases cellular NAD+ levels faster and sustains them longer than NMN, possibly due to better cell membrane permeability and stability in plasma.
Why is the powder yellow?
Pure NMNH is naturally yellow due to its reduced chemical structure. If your NMNH turns white, it has likely oxidized back into NMN (which is white). We guarantee a bright yellow powder upon delivery.
Can I use NMNH in regular capsules?
It is possible but risky due to oxidation. We strongly recommend using acid-resistant capsules or softgels and ensuring the bottling process is done under nitrogen protection to ensure shelf-life stability.
References
1.Zapata-Pérez, R., et al. "Reduced nicotinamide mononucleotide is a new and potent NAD+ precursor in mammalian cells and mice." FASEB Journal (2021).
2.Liu, Y., et al. "NMNH outperforms NMN in increasing NAD+ levels in various tissues." Nature Communications (Related research context).
3.Dollerup, O. L., et al. "A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men: safety, insulin-sensitivity, and lipid-mobilizing effects." American Journal of Clinical Nutrition (Comparative context).
4.Yang, Y., et al. "NAD+ metabolism: Bioenergetics, signaling and manipulation for therapy." Biochimica et Biophysica Acta (2016).
5.Recent Patent Filings on Reduced NMN Synthesis and Applications (2021-2024).
Related Products
Our Global Presence：Pioneer Biotech | Pioneer Bio Inc. | Kono Chem | Kono Chem (RU)
P&K INTERNATIONAL PTE. LTD.